dbACP: A Comprehensive Database of Anti-Cancer Peptides

7 result(s) have been found!

Accession Name Sequence Source/Organism Mechanism Assay Type Cell Line Cancer Type Activity
dbacp07111 LyeTx-I-b IWLTALKFLGKNLGKLAKQQLAKL Synthetic Synergistic autophagic death via AKT inhibition. MTT assay MDA-MB-231 Breast Cancer IC50 = 2.47 µM
dbacp07309 LyeTxI-b IWLTALKFLGKNLGKLAKQQLAKL Synthetic Apoptosis induction and immune modulation. MTT assay 4T1 Breast Cancer IC50 = 6.5 ± 5.30 µM
dbacp07310 LyeTxI-b IWLTALKFLGKNLGKLAKQQLAKL Synthetic Apoptosis induction and immune modulation. MTT assay MCF-7 Breast Cancer IC50 = 7.34 ± 3.09 µM
dbacp07311 LyeTxI-b IWLTALKFLGKNLGKLAKQQLAKL Synthetic Apoptosis induction and immune modulation. MTT assay MDA-MB-231 Breast Cancer IC50 = 5.77 ± 0.83 µM
dbacp07934 LyeTx-I-b IWLTALKFLGKNLGKLAKQQLAKL Synthetic Membrane disruption, necroptosis, limited apoptosis MTT/Resazurin dye assay U-87-MG Brain Tumor IC50 = 29.20 ± 7.96 µM
dbacp07935 LyeTx-I-b IWLTALKFLGKNLGKLAKQQLAKL Synthetic Membrane disruption, necroptosis, limited apoptosis MTT/Resazurin dye assay U-373-MG Brain Tumor IC50 = 20.94 ± 5.18 µM
dbacp07936 LyeTx-I-b IWLTALKFLGKNLGKLAKQQLAKL Synthetic Membrane disruption, necroptosis, limited apoptosis MTT/Resazurin dye assay SH-SY5Y Brain Tumor IC50 = 93.80 ± 2.17 µM